IL91415A - Antiviral preparations containing a history of adenosine, their salts or metabolites - Google Patents
Antiviral preparations containing a history of adenosine, their salts or metabolitesInfo
- Publication number
- IL91415A IL91415A IL9141589A IL9141589A IL91415A IL 91415 A IL91415 A IL 91415A IL 9141589 A IL9141589 A IL 9141589A IL 9141589 A IL9141589 A IL 9141589A IL 91415 A IL91415 A IL 91415A
- Authority
- IL
- Israel
- Prior art keywords
- ipa
- virus
- composition
- cells
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE882585A IE882585L (en) | 1988-08-25 | 1988-08-25 | Viral treatment system |
Publications (2)
Publication Number | Publication Date |
---|---|
IL91415A0 IL91415A0 (en) | 1990-04-29 |
IL91415A true IL91415A (en) | 1995-08-31 |
Family
ID=11035556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9141589A IL91415A (en) | 1988-08-25 | 1989-08-24 | Antiviral preparations containing a history of adenosine, their salts or metabolites |
Country Status (12)
Country | Link |
---|---|
US (1) | US5681831A (de) |
EP (1) | EP0355825A3 (de) |
JP (1) | JP3237836B2 (de) |
KR (1) | KR900002786A (de) |
AU (1) | AU636574B2 (de) |
CA (1) | CA1339854C (de) |
DK (1) | DK418489A (de) |
FI (1) | FI893948A (de) |
IE (1) | IE882585L (de) |
IL (1) | IL91415A (de) |
OA (1) | OA09427A (de) |
ZA (1) | ZA896450B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
PH30703A (en) * | 1990-06-21 | 1997-09-16 | Patrick T Prendergast | Administering particular compounds against variousparasites, mycoplasmas, other indications and otheer indications and other infections. |
CA2251733A1 (en) * | 1996-04-17 | 1997-10-23 | Patrick T. Prendergast | Dhea combination therapy |
US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
FR2759091B1 (fr) * | 1997-02-06 | 1999-03-19 | Expertises Ind Et | Procede biologique d'obtention de nouveaux derives de l'adenosine et les compositions pharmaceutiques qui les contiennent |
WO1998047516A1 (en) * | 1997-04-17 | 1998-10-29 | Prendergast Patrick T | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors |
US6800616B2 (en) | 1998-02-26 | 2004-10-05 | Supergen, Inc. | Treatment of HIV infections |
CA2552596A1 (en) * | 2005-08-09 | 2007-02-09 | Solvay Pharmaceuticals B.V. | Methods and systems for determining mid-value titers |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
PT2691530T (pt) | 2011-06-10 | 2018-05-10 | Univ Oregon Health & Science | Glicoproteínas e vectores recombinantes cmv |
CA2789539A1 (en) | 2011-09-12 | 2013-03-12 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
EP2848937A1 (de) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Verfahren zur Identifizierung neuartiger HIV-1-Immunogene |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759011A (fr) * | 1969-11-17 | 1971-05-17 | Wellcome Found | Aminopurines |
DE2052596A1 (de) * | 1970-10-27 | 1972-05-04 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten |
US3758684A (en) * | 1971-09-07 | 1973-09-11 | Burroughs Wellcome Co | Treating dna virus infections with amino purine derivatives |
US3966916A (en) * | 1972-09-09 | 1976-06-29 | Boehringer Mannheim G.M.B.H. | N(6)-disubstituted adenoisine compounds and therapeutic compositions |
US4016262A (en) * | 1973-08-01 | 1977-04-05 | Boehringer Mannheim G.M.B.H. | Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds |
US4007186A (en) * | 1974-09-20 | 1977-02-08 | Emanuel Carl F | Process for preparing uric acid |
JPS5712999A (en) * | 1980-06-25 | 1982-01-22 | Chiyokichi Iizuka | Antibiral agent and its preparation |
JPS57171998A (en) * | 1981-04-15 | 1982-10-22 | Fujisawa Pharmaceut Co Ltd | Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same |
US4558051A (en) * | 1983-10-11 | 1985-12-10 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same |
US5093318A (en) * | 1983-11-01 | 1992-03-03 | Scripps Clinic And Research Foundation | Immunostimulating guanosine derivatives and their pharmaceutical compositions |
US4687733A (en) * | 1984-01-30 | 1987-08-18 | Ohio State University | Early cancer detection method |
US4657897A (en) * | 1984-06-22 | 1987-04-14 | Warner-Lambert Company | N6 -substituted adenosines for treating pain |
US4791103A (en) * | 1985-02-08 | 1988-12-13 | Warner-Lambert Company | 2,N6 -disubstituted adenosines, derivatives and methods of use |
US4605644A (en) * | 1985-02-07 | 1986-08-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia employing ribose and adenine |
AU618723B2 (en) * | 1986-10-06 | 1992-01-09 | University Of Virginia Alumni Patents Foundation, The | Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
JPH0723394B2 (ja) * | 1986-11-27 | 1995-03-15 | 日本臓器製薬株式会社 | 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
FI880405A (fi) * | 1987-02-04 | 1988-08-05 | Ciba Geigy Ag | Adenosin-5'-karboxamidderivat. |
IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
IL86009A (en) * | 1987-04-10 | 1991-09-16 | Us Health | Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases |
AU637975B2 (en) * | 1988-06-09 | 1993-06-17 | Temple University - Of The Commonwealth System Of Higher Education | Therapeutic uses of 2',5'-oligoadenylate derivatives |
US5292725A (en) * | 1988-08-25 | 1994-03-08 | Prendergast Patrick T | Administering particular compounds against various parasites, mycoplasmas, other indications and other infections |
-
1988
- 1988-08-25 IE IE882585A patent/IE882585L/xx not_active Application Discontinuation
-
1989
- 1989-08-23 FI FI893948A patent/FI893948A/fi not_active Application Discontinuation
- 1989-08-24 DK DK418489A patent/DK418489A/da not_active Application Discontinuation
- 1989-08-24 CA CA000609342A patent/CA1339854C/en not_active Expired - Fee Related
- 1989-08-24 EP EP19890115606 patent/EP0355825A3/de not_active Withdrawn
- 1989-08-24 ZA ZA896450A patent/ZA896450B/xx unknown
- 1989-08-24 OA OA59631A patent/OA09427A/xx unknown
- 1989-08-24 IL IL9141589A patent/IL91415A/en not_active IP Right Cessation
- 1989-08-25 JP JP22015889A patent/JP3237836B2/ja not_active Expired - Fee Related
- 1989-08-25 AU AU40256/89A patent/AU636574B2/en not_active Ceased
- 1989-08-25 KR KR1019890012173A patent/KR900002786A/ko not_active Application Discontinuation
-
1994
- 1994-05-31 US US08/251,659 patent/US5681831A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5681831A (en) | 1997-10-28 |
JPH02237996A (ja) | 1990-09-20 |
CA1339854C (en) | 1998-05-05 |
IL91415A0 (en) | 1990-04-29 |
EP0355825A3 (de) | 1991-12-27 |
AU4025689A (en) | 1990-03-01 |
JP3237836B2 (ja) | 2001-12-10 |
FI893948A (fi) | 1990-02-26 |
ZA896450B (en) | 1991-04-24 |
OA09427A (en) | 1992-10-15 |
IE882585L (en) | 1990-02-25 |
EP0355825A2 (de) | 1990-02-28 |
FI893948A0 (fi) | 1989-08-23 |
DK418489D0 (da) | 1989-08-24 |
DK418489A (da) | 1990-02-26 |
AU636574B2 (en) | 1993-05-06 |
KR900002786A (ko) | 1990-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4861759A (en) | Antiviral compositions and methods | |
IL91415A (en) | Antiviral preparations containing a history of adenosine, their salts or metabolites | |
EP0291633B1 (de) | Verwendung von 3'-Azido-3'-deoxythymidin zur Behandlung oder Vorbeugung von menschlichen Retrovirus-Infektionen | |
Barnard et al. | Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid | |
US6413944B1 (en) | Triciribine and analogs as antiviral drugs | |
Schinazi et al. | Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and-thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus | |
Cohen et al. | Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A | |
Soike et al. | Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy) propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys | |
Hosoya et al. | Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro | |
US6075050A (en) | Compound for inhibiting HIV infectivity | |
Whitley et al. | Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host | |
JPH031309B2 (de) | ||
BRPI0208411B1 (pt) | composto, composição farmacêutica tópica para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto | |
Streicher et al. | In vitro inhibition of human herpesvirus-6 by phosphonoformate | |
US5254539A (en) | Method of treating HIV with 2',3'-dideoxyinosine | |
US4704357A (en) | Immortalized T-lymphocyte cell line for testing HTLV-III inactivation | |
EP0216511B1 (de) | Hemmung der In-vitro-Infektivität und des zytopathischen Effektes von HTLV-III/LAV durch 2'3'-Dideoxycytidin | |
US5292725A (en) | Administering particular compounds against various parasites, mycoplasmas, other indications and other infections | |
JPS59186985A (ja) | ジメチルアミノメチレン化された抗ヘルペス化合物 | |
EP1169036B1 (de) | Antivirale verwendungen von leflunomid produkten | |
Ihara et al. | Natural Killing of Varicella‐Zoster Virus (VZV)‐Infected Fibroblasts in Normal Children, Children with VZV Infections, and Children with Hodgkin's Disease | |
JPH01149730A (ja) | レトロウイルス増殖抑制剤 | |
EP0462621A2 (de) | Verwendung von speziellen Verbindungen zur Herstellung pharmazeutischer Zubereitungen zur Behandlung gegen verschiedene Parasiten, Mykoplasmen, andere Indikationen und andere Infektionen | |
AU721657B2 (en) | Administering particular compounds against various parasites, mycoplasmas, other indications and other infections | |
AU696833B2 (en) | Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
RH1 | Patent not in force |